Pluristem Therapeutics (PSTI) Plans Public Offering of Common Stock and Warrants, and Concurrent Registered Direct Offering of Common Stock
Tweet Send to a Friend
Pluristem Therapeutics Inc. (Nasdaq: PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy product candidates, announced today that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
